Additionally, genome-wide association studies (GWAS) and other cellular techniques studying gene expression and regulation will undoubtedly change our understanding of how CYP1B1 mutations contribute to the pathogenesis of glaucoma and cancer. Here, CYP1B1 is linked to cancer.